Celldex Therapeutics Inc.

NASDAQ: CLDX
Share price (11/21/24): $26.22
Market cap (11/21/24): $1.740 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 146 pages Agreement and Plan of Merger by and Among Kolltan Pharmaceuticals, Inc., Celldex Therapeutics, Inc., Connemara Merger Sub 1 Inc., Connemara Merger Sub 2 LLC, and Shareholder Representative Services LLC, Solely in Its Capacity as the Stockholders Representative November 1, 2016

from 8-K 75 pages Agreement and Plan of Merger by and Among Celldex Therapeutics, Inc., Cottrell Merger Sub, Inc. and Curagen Corporation May 28, 2009

from 425 75 pages Agreement and Plan of Merger by and Among Celldex Therapeutics, Inc., Cottrell Merger Sub, Inc. and Curagen Corporation May 28, 2009

from 8-K 79 pages Agreement and Plan of Merger by and Among Avant Immunotherapeutics, Inc., Callisto Merger Corporation and Celldex Therapeutics, Inc. Dated as of October 19, 2007

from 425 79 pages Agreement and Plan of Merger by and Among Avant Immunotherapeutics, Inc., Callisto Merger Corporation and Celldex Therapeutics, Inc. Dated as of October 19, 2007

from 8-K ~5 pages Plan of reorganization, merger, acquisition or similar

from 8-K ~50 pages Plan of reorganization, merger, acquisition or similar

from 8-K ~50 pages Asset Purchase Agreement